SPT — AGM Information 2021

Aug 9, 2021

ScinoPharm Taiwan, Ltd. Notice of 2021 Annual General Shareholders’ Meeting (Summary Translation)

1. Shareholders are encouraged to exercise their voting rights through TDCC’s e-Voting service during the COVID-19 (Novel Coronavirus Disease 2019) pandemic. If shareholders intend to attend Shareholders’ Meeting, each shareholder shall put on a face mask at all times. Our staff will help to measure the body temperature at the entrance. If the temperature is higher than 37.5 ° C (forehead temperature) or 38 ° C (ear temperature), shareholders won’t be allowed to enter the meeting site.

2. In case that the meeting site is changed due to pandemic, please refer to the MOPS material information.

The 2021 Annual General Shareholders’ Meeting (the “Meeting”) of ScinoPharm Taiwan, Ltd. (the “Company”) will be convened at 10:00 a.m., Tuesday, June 29, 2021 at The Auditorium, Southern Taiwan Science Park Administration Building (1F, 22 Nan-Ke 3[rd] Road, Southern Taiwan Science Park, XinShi District, Tainan City 741, Taiwan, R.O.C.).

1. The agenda for the Meeting is as follows:

   • I. Report Items

     • (1) 2020 Business Report.

     • (2) Audit Committee’s Review Report on 2020 Financial Results.

     • (3) 2020 Compensations for Employees and Directors.

     • (4) Proposed Amendments to the Rules of Procedure for Board of Directors Meeting of the Company.

   • II. Ratification Items

     • (1) Ratification of 2020 Business Report and Financial Statements.

     • (2) Ratification of the Proposed Distribution of 2020 Earnings.

   • III. Matters proposed for discussion and resolution

     • (1) Proposed Amendments to the Rules of Procedures for Shareholders’ Meeting of the Company.

   • IV. Election

     • (1) The 10th Election of Board of Directors (including Independent Directors)

   • V. Other Proposals

     • (1) Proposed release the Directors (including Independent Directors) elected and their representatives from non-competition restrictions

   • VI. Extemporary motions

1

1. Proposal for distribution of 2020 profits has been resolved by the Board of Directors as follows: Proposed cash dividend is $395,369,611, which is equivalent to $0.50 per share. Upon the approval of Annual General Shareholders’ Meeting, it is proposed that the Board of Directors be authorized to resolve the distribution record date.

2. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from May 1 2021 to June 29, 2021.

3. If any shareholder solicits for a proxy, the Company will disclose the summarization of the solicitation prepared by the Company on the website of the Securities and Futures Institute (http://free.sfi.org.tw) on May 28, 2021. If any investor wishes to make inquiries, please log into the “free inquiry system for published information of proxy” on the website, and click the right side “entrance to published information of proxy” and input the key words for the inquiry.

4. The shareholder’s voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from May 29, 2021 through June 26, 2021. Please log in the “Stockvote” established by Taiwan Depository & Clearing Corporation at http://www.stockvote.com.tw.

5. The institution for tallying and verifying proxy forms of 2021 general shareholders’ meeting is Stock Registration Department, President Securities Corporation.

6. If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http://mops.twse.com.tw). Please log into said website, and click “electronic books”, key in the Year “2021,” select the code of the Company “1789,” and read references related to the shareholders’ meeting.

Board of Directors ScinoPharm Taiwan, Ltd.

2